German Immuno-Oncology Biotech partners up with Biotech Giant Amgen
Immatics and Amgen have inked a deal to develop bispecific drug candidates for cancer that…
January 9, 2017 - 2 minutes
Immatics
Leading German Biotechs MorphoSys and Immatics partner to pump up their Immuno-Oncology Therapies
Two German biotechs with highly successful platforms join forces to fight cancer. MorphoSys and Immatics…
August 25, 2015 - 2 minutes
European’s First Personalized Vaccines to Treat Brain Cancer
A novel concept of fully personalized therapeutic cancer vaccines, called Glioma Actively Personalized VAccine Consortium…
October 20, 2014 - 3 minutes
